Overview
Portfolio
More
Longviewinnovation
Wilmington, United States
Focuses on turning breakthrough scientific discoveries from leading universities and DOE labs into commercial companies, supporting early‑stage ventures that bridge cutting‑edge research and market adoption.
Portfolio
14+
Employees
5+
Founded
N/A
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Longviewinnovation
Focuses on turning breakthrough scientific discoveries from leading universities and DOE labs into commercial companies, supporting early‑stage ventures that bridge cutting‑edge research and market adoption.
Portfolio
14+
Employees
5+
Founded
N/A
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 14 of 14 matched portfolio companies
Abatatx offers a managed WordPress hosting service that automates domain verification, DNS configuration, and account provisioning to prevent common setup errors. The platform provides guided onboarding, real‑time support, and monitoring alerts, enabling small to medium businesses and individual site owners to launch and maintain WordPress sites with minimal downtime and technical effort.
Funding: $110.3M
Rough estimate of the amount of funding raised
Funding: $110.3M
Rough estimate of the amount of funding raised
Athos Therapeutics develops AI-based precision therapeutics targeting Inflammatory Bowel Disease and other autoimmune conditions by integrating medicinal chemistry with machine learning to identify novel drug compounds. Their platform utilizes human clinical and molecular datasets to synthesize small molecules that effectively target key disease factors, improving treatment outcomes for patients.
Funding: $59.7M
Rough estimate of the amount of funding raised
Funding: $59.7M
Rough estimate of the amount of funding raised
Carisma Therapeutics develops chimeric antigen receptor macrophages (CAR-Macrophages) to target solid tumors by engineering a patient's own immune cells to enhance tumor infiltration and activate anti-tumor immunity. This approach addresses the challenges of immunosuppressive tumor microenvironments and antigen heterogeneity, offering a potential long-term treatment strategy for cancer patients.
Funding: $30.0M
Rough estimate of the amount of funding raised
Funding: $30.0M
Rough estimate of the amount of funding raised
EnaChip develops micro-magnetic components and devices for semiconductor applications, enhancing performance in electronic systems. The company's technology addresses the need for miniaturized, efficient components that improve energy efficiency and reduce the size of electronic devices.
Funding: $7.9M
Rough estimate of the amount of funding raised
Funding: $7.9M
Rough estimate of the amount of funding raised
Exyn Technologies develops modular software for autonomous aerial robots that capture real-time, colorized 3D point clouds in GPS-denied environments. This technology enables efficient mapping and data collection in complex and hazardous locations, eliminating the need for human control or pre-existing infrastructure.
Inne develops a hormone-based mini lab that utilizes saliva samples to monitor progesterone levels, enabling women to identify their unique fertile windows and track menstrual cycles. This technology provides actionable insights for women seeking to understand their fertility and optimize their chances of conception.
Funding: $20.3M
Rough estimate of the amount of funding raised
Funding: $20.3M
Rough estimate of the amount of funding raised
Instrumems Inc develops nano-sensors that accurately measure temperature, velocity, and humidity for various industrial applications. These sensors provide real-time data to enhance environmental monitoring and improve operational efficiency in sectors such as manufacturing and agriculture.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
Light is a financial platform that automates general ledger management, accounts receivable, and accounts payable processes for multinational companies using AI-driven analytics and real-time reporting. This solution addresses the complexities of financial operations by streamlining compliance and enhancing efficiency across diverse currencies and regulatory environments.
Funding: $13.0M
Rough estimate of the amount of funding raised
Funding: $13.0M
Rough estimate of the amount of funding raised
MOBILion Systems utilizes high-resolution ion mobility mass spectrometry (HRIM-MS) to detect and analyze complex molecules that traditional methods often miss. Their MOBIE platform enhances analytical characterization, enabling faster and more accurate identification of challenging analytes in pharmaceutical, environmental, and biomarker research.
Funding: $110.4M
Rough estimate of the amount of funding raised
Funding: $110.4M
Rough estimate of the amount of funding raised
Opti is a financial app that utilizes algorithmic portfolio optimization to combine multiple low-cost funds, providing users with a tailored investment strategy that minimizes fees while maximizing returns. The platform addresses the challenge of high management fees in traditional funds by offering a cost-effective alternative with a total expense ratio of approximately 0.70%.
Funding: $5.3M
Rough estimate of the amount of funding raised
Funding: $5.3M
Rough estimate of the amount of funding raised
Optimeos Life Sciences has developed a novel nanoparticle platform for the intracellular delivery of RNA and DNA therapeutics, enabling the co-encapsulation of multiple active pharmaceutical ingredients while enhancing tissue targeting and reducing immune activation. This technology addresses the limitations of traditional lipid nanoparticle systems, offering a superior dosing profile for more effective disease modification.
Funding: $6.8M
Rough estimate of the amount of funding raised
Funding: $6.8M
Rough estimate of the amount of funding raised
Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.
Funding: $186.0M
Rough estimate of the amount of funding raised
Funding: $186.0M
Rough estimate of the amount of funding raised
Somalytics develops miniature eye-tracking sensors that enhance human-machine interaction in wearables and industrial safety applications. These sensors provide precise tracking capabilities, improving operational efficiency and safety in environments where traditional tracking methods are inadequate.
Funding: $1.9M
Rough estimate of the amount of funding raised
Funding: $1.9M
Rough estimate of the amount of funding raised
Vi provides a digital platform offering personalized support and expert guidance for women navigating perimenopause and menopause symptoms. The platform delivers tailored content, symptom tracking, and access to certified menopause professionals for individual consultation. This service helps organizations support female employees, aiming to reduce absence and maintain team performance during this life stage.